# China NMPA Drug Inspection - Shaanxi Kangyu Pharmaceutical Co., Ltd. - Haijinsha

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shaanxi-kangyu-pharmaceutical-co-ltd/a423753f-7aa8-46aa-98fe-f10aed37f18d/
Source feed: China

> China NMPA drug inspection for Shaanxi Kangyu Pharmaceutical Co., Ltd. published November 25, 2020. Drug: Haijinsha. The Shaanxi Provincial Drug Administration released its 11th Drug Quality Bulletin of 2020 on November 25, following a s

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Shaanxi Province Drug Quality Bulletin (Issue 11, 2020, Serial No. 21)
- Company Name: Shaanxi Kangyu Pharmaceutical Co., Ltd.
- Publication Date: 2020-11-25
- Drug Name: Haijinsha
- Inspection Finding: The following items are non-compliant and do not meet the requirements: [Identification], [Inspection].
- Action Taken: The drug regulatory authorities have taken necessary control measures and are investigating and handling the matter in accordance with relevant laws and regulations.
- Summary: The Shaanxi Provincial Drug Administration released its 11th Drug Quality Bulletin of 2020 on November 25, following a series of sampling inspections conducted to ensure public medication safety. The report identified three batches of non-compliant drugs from two manufacturers: Shaanxi Hanyi Shengcaotang Pharmaceutical Co., Ltd. and Shaanxi Kangyu Pharmaceutical Co., Ltd. The affected products included Beichaihu, Lygodium japonicum, and Prepared Aconitum carmichaelii. According to the findings from the Xi'an Municipal Institute for Food and Drug Control, these products failed to meet the regulatory standards established in the 2015 Edition of the Chinese Pharmacopoeia (Part I). The main violations concerned failures in physical appearance, identification accuracy, and general inspection criteria. In response to these findings, provincial and local regulatory departments have implemented immediate control measures for the involved units. Necessary administrative actions, including formal investigations and legal handling of the non-compliant batches, are being carried out in accordance with Chinese drug supervision laws to mitigate risks to public health.

Company: https://www.globalkeysolutions.net/companies/shaanxi-kangyu-pharmaceutical-co-ltd/df5c26e7-0d85-4cac-8a08-979693e7d273/